Overview

Immediate Release Versus Slow Release Carvedilol in Heart Failure

Status:
Unknown status
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
Assessment of clinical effect and treatment quality of immediate release carvedilol (IR) versus slow release carvedilol (SR) in patients with HFrEF
Phase:
Phase 4
Details
Lead Sponsor:
Seoul National University Bundang Hospital
Collaborator:
Chong Kun Dang Pharmaceutical Corp.
Treatments:
Carvedilol